Wave Life Sciences
About:
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Website: http://wavelifesciences.com
Twitter/X: wavelifesci
Top Investors: Fidelity, RA Capital Management, Cormorant Asset Management, Foresite Capital, Teva Pharmaceuticals
Description:
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
$867M
$100M to $500M
Boston, Massachusetts, United States
2012-01-01
info(AT)wavelifesci.com
Greg Verdine, Takeshi Wada
251-500
2024-09-24
Public
© 2025 bioDAO.ai